BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8159813)

  • 1. Setting health-protective soil concentrations for dermal contact allergens: a proposed methodology.
    Horowitz SB; Finley BL
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):31-47. PubMed ID: 8159813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using human sweat to extract chromium from chromite ore processing residue: applications to setting health-based cleanup levels.
    Horowitz SB; Finley BL
    J Toxicol Environ Health; 1993 Dec; 40(4):585-99. PubMed ID: 8277520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe concentrations for dermal allergens in the environment.
    Nethercott JR; Finley B; Horowitz S; Paustenbach D
    N J Med; 1994 Oct; 91(10):694-7. PubMed ID: 7800281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the allergic contact dermatitis hazard posed by chromium-contaminated soil: identifying a "safe" concentration.
    Paustenbach DJ; Sheehan PJ; Paull JM; Wisser LM; Finley BL
    J Toxicol Environ Health; 1992 Sep; 37(1):177-207. PubMed ID: 1522610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the human health risks posed by exposure to chromium-contaminated soils.
    Sheehan PJ; Meyer DM; Sauer MM; Paustenbach DJ
    J Toxicol Environ Health; 1991 Feb; 32(2):161-201. PubMed ID: 1995927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of chromium allergy in the United States and its implications for setting soil cleanup: a cost-effectiveness case study.
    Proctor DM; Fredrick MM; Scott PK; Paustenbach DJ; Finley BL
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):27-37. PubMed ID: 9784430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the adequacy of maximum contaminant levels as health-protective cleanup goals: an analysis based on Monte Carlo techniques.
    Finley BL; Scott P; Paustenbach DJ
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):438-55. PubMed ID: 8128005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexavalent chromium-contaminated soils: options for risk assessment and risk management.
    Felter SP; Dourson ML
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):43-59. PubMed ID: 9056500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of chromium induced allergic contact dermatitis with 54 volunteers: implications for environmental risk assessment.
    Nethercott J; Paustenbach D; Adams R; Fowler J; Marks J; Morton C; Taylor J; Horowitz S; Finley B
    Occup Environ Med; 1994 Jun; 51(6):371-80. PubMed ID: 8044228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of the allergic dermatitis potential of environmental exposure to hexavalent chromium.
    Finley BL; Paustenbach DJ; Nethercott J; Fowler J
    J Toxicol Environ Health; 1995 Mar; 44(3):377-83. PubMed ID: 7897698
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin application of glutathione and iron sulfate can inhibit elicitation of allergic contact dermatitis from hexavalent chromium.
    Lejding T; Engfeldt M; Bruze M; Isaksson M; Svedman C; Zimerson E; Verma K; Mowitz M
    Contact Dermatitis; 2020 Jan; 82(1):45-53. PubMed ID: 31584201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational dermatoses in health care workers evaluated for suspected allergic contact dermatitis.
    Suneja T; Belsito DV
    Contact Dermatitis; 2008 May; 58(5):285-90. PubMed ID: 18416759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt-containing alloys and their ability to release cobalt and cause dermatitis.
    Julander A; Hindsén M; Skare L; Lidén C
    Contact Dermatitis; 2009 Mar; 60(3):165-70. PubMed ID: 19260915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatological toxicity of hexavalent chromium.
    Shelnutt SR; Goad P; Belsito DV
    Crit Rev Toxicol; 2007 Jun; 37(5):375-87. PubMed ID: 17612952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact dermatitis in the textile industry: a review of 72 patients.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1996 Dec; 7(4):226-30. PubMed ID: 8955486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of previously patch-tested patients referred to a contact dermatitis clinic.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1997 Mar; 8(1):10-4. PubMed ID: 9066841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature.
    de Waard-van der Spek FB; Oranje AP
    Dermatology; 2009; 218(2):119-25. PubMed ID: 18946202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment of the allergic dermatitis potential of environmental exposure to hexavalent chromium.
    Stern AH; Bagdon RE; Hazen RE; Marzulli FN
    J Toxicol Environ Health; 1993 Dec; 40(4):613-41. PubMed ID: 8277522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.